In the United States, over six million children have asthma and over 130,000 children are hospitalized yearly due to asthma exacerbations. Children with difficult-to-treat and/or severe asthma have the highest morbidity and mortality. In addition to ensuring assessment and management per existing guidelines, there is a need for more precise and personalized approaches to asthma management for these patients. This includes identification of phenotypes and tailoring medication choice based on underlying pathophysiology. This talk will address the fundamentals of identifying difficult-to-treat and severe asthma patients and outline steps to create a comprehensive asthma assessment and management plan.
This talk will focus on the ambulatory management of asthma in the adult. We will review the concept of asthma control (as opposed to severity) and how it is assessed. A systematic approach to achieving good asthma control, as developed by the National Asthma Education and Prevention Program, will be reviewed. In addition, we will consider novel therapeutic approaches that have been studied since the release of the last set of guidelines in 2007, including intermittent inhaled steroids in mild asthma, anticholinergic bronchodilators, bronchial thermoplasty, and anti-IL5 monoclonal antibody.
This lecture will address management of cigarette-smoking-related lung diseases, chronic bronchitis, and emphysema, and feature prevention (smoking abstinence and smoking cessation) and interventions (pharmacologic and nonpharmacologic). COPD is now the third most common cause of death in the United States. To improve care for their patients with COPD, participants will learn about diagnosing COPD, assessing its severity, and adjusting therapy according to that assessment. The speaker will also touch upon management of acute exacerbations of COPD in the ambulatory setting.
Asthma in children is all too often not well controlled. It remains one of the most common chronic illnesses you will manage in your office and one of the most frequent reasons why children are admitted to the hospital. I will discuss recent updates on managing asthma exacerbations with inhaled and oral steroids including the risks and benefits of dexamethasone. In addition, I will review the safety of using long-acting beta agonists in combination with inhaled steroids in children. I will also provide recommendations on when to consider treatment with omalizumab, one of the new asthma biological therapies, which has been approved for children as young as six years of age.
Asthma Update 2018: What's New Since the 2007 National Asthma Guidelines? (Recorded at Pri-Med East)
This session will focus on the diagnosis and treatment of asthma in the ambulatory setting, with an emphasis on new developments in the last year. It will cover: measurement of exhaled nitric oxide in the diagnosis and assessment of asthma, safety of long-acting beta-agonists in the treatment of asthma, use of long-acting anticholinergic bronchodilators for asthma, and novel biologic therapies for asthma. We will also review teaching the use of inhalers in asthma, including metered-dose inhalers, dry-powder inhalers, breath-actuated inhalers, and soft-mist inhalers.
This talk will focus on several common and confusing topics and scenarios that often arise in the primary care practice setting. The faculty will review an approach to patients who come into the clinic with a diagnosis of asthma for whom the clinical suspicion is low that includes spirometry and methacholine challenge interpretation. Next, the talk will cover the evidence for using long-term oxygen therapy in respiratory patients and the various oxygen delivery systems. The faculty will also discuss the approach to chronic cough when typical therapies have failed to improve systems as well as current evidence and approach to lung cancer screening. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/6/2020 and they are subject to change as new information is published.
Meet your next patient: follow this case of a 23-year-old woman with shortness of breath from presentation to diagnosis, management, and monitoring to improve your care of patients with difficult-to-control asthma. Please note that any data, indications, and guidelines presented in this activity are current as of 6/18/2020 and they are subject to change as new information is published.
A two-part podcast series in partnership with Learn More Breathe BetterSM, a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
This short curriculum cuts to the heart of primary and secondary cardiovascular disease prevention in people with type 2 diabetes. The following two activities will help you individualize treatment and optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences. This curriculum includes: • 1 educational video webcast • 1 simulated digital “tele-visit” with a standardized patient Pri-Med has partnered with RealCME to offer the Pri-Med community the innovative opportunity to schedule time for a simulated digital “tele-visit” with a standardized patient (SP), who is trained to simulate the symptoms and characteristics of patients you see in your practice. This interactive session is designed to complement the “Heart of the Matter” video webcast by enabling you to practice shared-decision making. You can benefit from scheduling this activity after viewing the educational webcast, but you are also welcome to sign up for this simulated digital tele-visit activity without viewing the webcast. The “patient” is a 52-year-old who is following up with you for their type 2 diabetes, with a history of obesity, hypertension, hypercholesterolemia, and coronary artery disease. The patient is on maximum dose of metformin, with an A1c today of 8.6%. A highly experienced observer will review your session and send you feedback via a customized scorecard. There is no cost for this activity, but there are limited sessions available. To schedule your free virtual visit, you will need this access code: PriMed2020 Link to activity: https://m.pri-med.com/T1ZMR080r000iMb30E5hYA0 Access code: PriMed2020
Part 1: The 2020 Focused Updates to the Asthma Management Guidelines: How Have the Asthma Guidelines Changed?
In this episode, James P. Kiley, Ph.D., NHLBI Division of Lung Diseases Director, will discuss the background behind the updated asthma guidelines, outlining the key topic areas covered, the rigorous process used to update the recommendations, and the new features designed to help clinicians implement them in practice.
In this episode, Michelle M. Cloutier, M.D., chair of the National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) Expert Panel Working Group and professor emerita of UCONN School of Medicine, will provide highlights from the updated recommendations to the national asthma guidelines that are most relevant to primary care providers and share how clinicians can turn the new information into practice. Understanding the 2020 Focused Updates to the Asthma Management Guidelines is a two-part podcast series informing clinicians about the updated asthma guidance, highlighting important changes to the recommendations, and discussing how these changes can improve diagnosis, treatment, and management of patients with asthma.
This session, recorded on 5/8/2020, will describe the recent advances in treatment for severe asthma. Faculty will use patient case examples to describe a systematic approach for assessing patients with difficult-to-control asthma and review the stepwise treatment of asthma. They will also discuss how primary care clinicians can help to identify patients in their practice who would benefit from further subtyping of their asthma and treatment with biologic therapies. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/8/2020 and they are subject to change as new information is published.
The Top Questions I Most Often Get Asked About: Hypertension, Polypharmacy in the Elderly, and Asthma
What do primary care providers need to know to know about hypertension, polypharmacy in the elderly, and asthma? Join cardiologist Karol Watson, geriatrician Lee Lindquist, and pulmonologist Sunjay Devarajan as they review important questions, they get asked about these three topics! Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/4/2020 and they are subject to change as new information is published.